# Orion Therapeutics, Inc. — Form D

Orion Therapeutics, Inc. of KNOXVILLE, TN, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-25. The offering totals $250K, of which $85K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-09-25
- Form: D
- Accession: 0001958173-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $250K
- Amount sold: $85K
- Remaining: $165K
- Investors: 4
- Date of first sale: 2024-09-10
- Revenue range: $1 - $1,000,000
- SEC file number: 021-524886

## Issuer

- Name: Orion Therapeutics, Inc.
- CIK: 0001958173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2641 OSPREY VISTA WAY, KNOXVILLE, TN, 37920
- Phone: 865-771-7024

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Richard Kern Fisher | Director | Knoxville, TN |
| Michael Kern McCaman | Director | Knoxville, TN |
| Deidra Kern Mountain | Director | Knoxville, TN |
| Richard Kern Fisher | Executive Officer | Knoxville, TN |
| Michael Kern McCaman | Executive Officer | Knoxville, TN |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-12-14](https://search.stillhousedata.com/formd/0001958173-22-000001) | D | $250K | $60K |

## More

- [CIK 1958173 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1958173&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001958173-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.